LOS ANGELES - The old joke is that of fast, cheap and good, you can have any two. But Francis Collins, director of the National Institute for Human Genome Research, says that's really no longer true in gene sequencing. (BioWorld Today)

WASHINGTON - Wide-ranging FDA legislation is scheduled for Senate review on Wednesday, but notably, the bill does not include a provision related to follow-on biologics. (BioWorld Today)